Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 23;9(9):E1397-E1403.
doi: 10.1055/a-1499-6988. eCollection 2021 Sep.

Risk of bleeding following double balloon enteroscopy in patients on continued antiplatelet and/or anticoagulation therapy

Affiliations

Risk of bleeding following double balloon enteroscopy in patients on continued antiplatelet and/or anticoagulation therapy

Himesh B Zaver et al. Endosc Int Open. .

Abstract

Background and study aims Anticoagulation (AC) and antiplatelet (AP) therapy may increase the risk of gastrointestinal bleeding after double balloon enteroscopy (DBE); however, limited data are currently available regarding the incidence. The aim of this study was to assess the incidence and clinical characteristics of post-DBE bleeding in patients on AC and AP therapy. Patients and methods The medical records of patients who underwent DBE between 2009 and 2013 at Mayo Clinic, Florida, were retrospectively reviewed. Patients were divided into three groups: 1) continued AP therapy; 2) AC therapy; and 3) neither AP nor AC at the time of DBE. Follow-up data were collected at 60 days and 1 year. Results A total of 683 patients were identified; 43 on AC, 183 on AP and 457 not on AP or AC therapy. The most common indication for DBE was obscure gastrointestinal bleeding in the groups on and not on AP (85.3 % vs 70.9 %, P < 0.0001). There was no statistical difference in post-DBE bleeding rates in patients on AP vs not on AP at 60 days (11.5 % vs 7.5 %, P = 0.12) or 1 year (19.9 % vs 15.7 %, P = 0.23). Rates of bleeding in patients on AC were 11.6 % within 60 days and 22.5 % within 1 year. Multivariate analysis reflected American Society of Anesthesiologist > 3 and indication for DBE of GI bleeding were independent risk factors for post-DBE bleeding within 1 year. Conclusions Continued antiplatelet use at the time of DBE was not an independent risk factor for bleeding post-DBE at 60 days or 1 year of follow up.

PubMed Disclaimer

Conflict of interest statement

Competing interests The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Summary of the study population.
Fig. 2
Fig. 2
Bleeding outcomes of patients on antiplatelet vs not on antiplatelet therapy at 60 days and 1 year.
Fig. 3
Fig. 3
Univariate and multivariate analysis of bleeding outcomes at 60 days and 1 year.

References

    1. Saygili F, Saygili S M, Oztas E. Examining the whole bowel, double balloon enteroscopy: Indications, diagnostic yield and complications. World J Gastrointest Endosc. 2015;7:247–252. - PMC - PubMed
    1. Rondonotti E. Capsule retention: prevention, diagnosis and management. Ann Transl Med. 2017;5:198. - PMC - PubMed
    1. Yamamoto H, Yano T, Kita H.New system of double-balloon enteroscopy for diagnosis and treatment of small intestinal disorders Gastroenterology 20031251556author reply 1556–1557 - PubMed
    1. Wang L, Xie M, Hong L et al.The Diagnostic yields and safety of double-balloon enteroscopy in obscure gastrointestinal bleeding and incomplete small bowel obstruction: comparison between the adults and elderly. Gastroenterol Res Pract. 2020;2020:8.121625E6. - PMC - PubMed
    1. Moschler O, May A, Muller M K et al.Complications in and performance of double-balloon enteroscopy (DBE): results from a large prospective DBE database in Germany. Endoscopy. 2011;43:484–489. - PubMed